Compare DHT Holdings Inc. (DHT) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DHT Holdings Inc. vs Halozyme Therapeutics Inc. Common Stock — how do they compare? DHT Holdings Inc. trades at $24.91 (market cap $3.82B), while Halozyme Therapeutics Inc. Common Stock trades at $109.67 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 3.3× DHT Holdings Inc.'s market cap, and DHT Holdings Inc. pays a 20.58% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold DHT Holdings Inc. for 0 Days and Halozyme Therapeutics Inc. Common Stock for 0 Days on average.
| DHT | HALO | |
|---|---|---|
Market Cap | $3.82B | $12.58B |
Volume | 3,845,643 | 2,179,278 |
Sector | Industrials | Health |
52-Week High | $24.93 | $115.22 |
52-Week Low | $11.20 | $61.63 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.10B | $14.49B |
Dividend Yield | 20.58% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About DHT Holdings Inc.
DHT Holdings operates a fleet of crude oil tankers that trade on international routes. Its fleet consists of very large crude carriers, or VLCCs.
Read more on DHT →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
